Why Pharma and Life Sciences Companies Choose Hyderabad for Their GCC
Hyderabad’s Quiet Rise in Pharma and Life Sciences GCCs
In the past decade, when European pharma and life sciences companies considered an India Global Capability Centre (GCC), Bangalore and Pune dominated the conversation. That has changed. Hyderabad now hosts over 350 GCCs and has emerged as India’s fastest-growing hub for life sciences, pharmaceuticals, and digital health.
The latest signal: ProPharma Group, a global leader in regulatory, clinical, and compliance services for life sciences, recently inaugurated its new GCC at Mindspace, HITEC City. ProPharma joins a growing list of life sciences and pharma majors who have chosen Hyderabad over the more obvious Bangalore default.
For European mid-market pharma, biotech, medical devices, CRO, and digital health companies evaluating India, the question is no longer “India or not”. It is “which Indian city, and why Hyderabad specifically?”
Why Life Sciences Companies Are Choosing Hyderabad
Three structural reasons drive the shift.
1. Pharma and life sciences ecosystem density
Hyderabad is already home to large parts of the Indian pharma industry, Dr. Reddy’s Laboratories, Aurobindo Pharma, Divis Labs, Bharat Biotech, Biological E, Hetero, Granules, MSN. The talent pool of regulatory affairs specialists, clinical operations managers, pharmacovigilance professionals, GxP-trained QA, and biostatisticians is genuinely deep in a way Bangalore (more software-led) and Pune (more automotive and engineering-led) are not. For a European pharma company, the practical translation is that hiring 50 senior regulatory and clinical professionals in a pharma GCC Hyderabad setup is materially easier than doing the same in Bangalore.
2. Government and infrastructure backing
Telangana’s state government has been unusually proactive on life sciences GCC attraction. The state operates dedicated industry parks, Genome Valley for biotech and pharma R&D, Pharma City for manufacturing, and HITEC City and Financial District for technology and shared services. The state government has signed direct agreements with multiple international universities and global corporations to anchor specific capability areas. The IGBC Gold-rated business parks like Mindspace, where ProPharma chose to set up, reflect infrastructure quality genuinely competitive with European Class A office space.
3. Lower talent cost vs Bangalore
For equivalent senior roles, fully-loaded compensation in Hyderabad typically runs 10 to 20 percent lower than Bangalore, while talent retention rates are higher (less competitive churn from Big Tech). For a mid-market European pharma company building a 30 to 100 person GCC, this is materially significant over a 3 to 5 year horizon.
What a Pharma GCC in Hyderabad Typically Does
A modern pharma or life sciences GCC in Hyderabad is rarely just a back-office. The functions most commonly built include:
- Regulatory affairs and submissions (US FDA, EMA, MHRA dossier preparation)
- Clinical operations support (study management, data management, statistical programming)
- Pharmacovigilance and drug safety (case processing, signal detection, aggregate reporting)
- Medical writing and medical affairs support
- Quality assurance and GxP compliance
- Real-world evidence and HEOR analytics
- Digital health engineering (mobile apps, connected devices, clinical decision support)
- IT, data engineering, and AI/ML for drug discovery
The maturity of these functions in Hyderabad GCCs is now such that significant parts of global regulatory submissions, clinical study design, and pharmacovigilance for a European parent can be done end-to-end from the GCC, with the parent retaining strategy and final accountability.
What This Means for European Mid-Market Life Sciences Companies
If you are a European biotech, specialty pharma, CRO, medical device, or digital health company in the 100 million to 1 billion euro revenue range, the operational case for a Hyderabad GCC is now well-established. The constraints that historically blocked the move, finding senior regulatory talent, integrating an India team with European clinical timelines, ensuring GxP compliance, are now solved problems with well-mapped templates.
A 30 to 80 person pharma GCC in Hyderabad can be operational within 100 days, with fully-loaded cost typically 40 to 60 percent lower than equivalent European hiring, and access to a regulatory and clinical talent pool deeper than what most European mid-market companies can recruit from at home.
How Airopa Helps
At Airopa Global, we help European mid-market life sciences companies set up dedicated GCCs in Hyderabad, with established government relationships in Telangana and operational templates that compress the typical 9 to 12 month setup timeline to 100 days. If you are evaluating Hyderabad for a pharma or life sciences GCC, we would be happy to talk.
Background news source: ProPharma’s Hyderabad GCC inauguration, originally reported by Telangana Rising.